1. Home
  2. ALKS vs MTH Comparison

ALKS vs MTH Comparison

Compare ALKS & MTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • MTH
  • Stock Information
  • Founded
  • ALKS 1987
  • MTH 1985
  • Country
  • ALKS Ireland
  • MTH United States
  • Employees
  • ALKS N/A
  • MTH N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • MTH Homebuilding
  • Sector
  • ALKS Health Care
  • MTH Consumer Discretionary
  • Exchange
  • ALKS Nasdaq
  • MTH Nasdaq
  • Market Cap
  • ALKS 5.1B
  • MTH 5.1B
  • IPO Year
  • ALKS 1991
  • MTH 1988
  • Fundamental
  • Price
  • ALKS $27.93
  • MTH $67.98
  • Analyst Decision
  • ALKS Strong Buy
  • MTH Buy
  • Analyst Count
  • ALKS 13
  • MTH 10
  • Target Price
  • ALKS $40.38
  • MTH $83.61
  • AVG Volume (30 Days)
  • ALKS 2.0M
  • MTH 1.2M
  • Earning Date
  • ALKS 07-29-2025
  • MTH 07-23-2025
  • Dividend Yield
  • ALKS N/A
  • MTH 2.52%
  • EPS Growth
  • ALKS N/A
  • MTH N/A
  • EPS
  • ALKS 2.09
  • MTH 8.78
  • Revenue
  • ALKS $1,513,770,000.00
  • MTH $6,216,250,000.00
  • Revenue This Year
  • ALKS N/A
  • MTH $3.99
  • Revenue Next Year
  • ALKS $3.33
  • MTH $7.59
  • P/E Ratio
  • ALKS $13.47
  • MTH $7.76
  • Revenue Growth
  • ALKS N/A
  • MTH N/A
  • 52 Week Low
  • ALKS $25.56
  • MTH $59.27
  • 52 Week High
  • ALKS $36.45
  • MTH $106.99
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 46.68
  • MTH 45.24
  • Support Level
  • ALKS $25.72
  • MTH $68.19
  • Resistance Level
  • ALKS $27.29
  • MTH $71.31
  • Average True Range (ATR)
  • ALKS 1.04
  • MTH 2.65
  • MACD
  • ALKS -0.11
  • MTH -0.57
  • Stochastic Oscillator
  • ALKS 46.62
  • MTH 5.47

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising ten states: Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Utah. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the homebuilding segment.

Share on Social Networks: